摘要
最近多种组学技术的进步和大规模并行测序的出现为精密医学的实施提供了技术支持。精准医学强调,通过强大的检测手段和临床特征的整合,异质性疾病可以很好地划分为更精确的亚型,因此临床医师应该为疾病亚型人群制定更准确的诊断和治疗策略,以最大限度地提高疗效并尽量减少不必要的副作用。肿瘤学处于精准医学的前沿,因为恶性肿瘤具有显着的异质性,并且是全国乃至全世界的主要死亡原因之一。肝细胞癌(HCC)的发病率和死亡率是一种非常不均匀的恶性肿瘤,在世界范围内不断增加,这使其成为一个重要的公共卫生问题。这种异质性影响关键信号通路,驱动表型变异,影响肿瘤进化,并对HCC治疗构成严重挑战。精准医学的应用将对HCC的诊断和治疗策略产生一定的影响。在此,我们总结了精准医学概念下高危人群筛查,预防,诊断,分期和治疗HCC的更新和挑战。
关键词: 肝细胞癌,精准医学,异质性,诊断和治疗策略,靶向治疗,免疫治疗
Current Medicinal Chemistry
Title:Precision Medicine: Update on Diagnosis and Therapeutic Strategies of Hepatocellular Carcinoma
Volume: 25 Issue: 17
关键词: 肝细胞癌,精准医学,异质性,诊断和治疗策略,靶向治疗,免疫治疗
摘要: Recent advances in multiple omics technologies and the advent of massively parallel sequencing provide technical supports for the implementation of precision medicine. The precision medicine emphasizes that heterogeneous diseases can be well classified into more precise subtypes by the powerful detection methods and integration of clinical features, so that the clinicians should develop more accurate diagnosis and therapeutic strategies for the disease subtype population in an effort to maximize the efficacy and minimize the unnecessary side effects. Oncology is at the forefront of precision medicine, as malignant tumors have significant heterogeneity and are among the leading causes of death nationally and worldwide. The incidence and mortality of Hepatocellular Carcinoma (HCC), a kind of extraordinarily heterogeneous malignancy, have been increasing worldwide, making it a major public health concern. Such heterogeneity affects key signaling pathways, driving phenotypic variation, influences tumor evolution, and poses severe challenges to HCC treatment. The application of precision medicine will have certain impact on HCC diagnosis and treatment strategies. Herein, we summarize the updates and challenges in high-risk population screening, prevention, diagnosis, staging and therapy of HCC under the concept of precision medicine.
Export Options
About this article
Cite this article as:
Precision Medicine: Update on Diagnosis and Therapeutic Strategies of Hepatocellular Carcinoma, Current Medicinal Chemistry 2018; 25 (17) . https://dx.doi.org/10.2174/0929867325666180117101532
DOI https://dx.doi.org/10.2174/0929867325666180117101532 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Alpha-1-Antichymotrypsin: A Common Player for Type 2 Diabetes and Alzheimer's Disease
Current Diabetes Reviews Recent Kinase and Kinase Inhibitor X-ray Structures: Mechanisms of Inhibition and Selectivity Insights
Current Medicinal Chemistry Regulation of Arylamine N-Acetyltransferases
Current Drug Metabolism Cordycepin in Anticancer Research: Molecular Mechanism of Therapeutic Effects
Current Medicinal Chemistry Cancer Stem-Cells Patents in the Context of their Therapeutic Purposes: Exploring the Latest Trends (2011-2015)
Recent Patents on Regenerative Medicine A Medicinal Chemist’s Perspective Towards Structure Activity Relationship of Heterocycle Based Anticancer Agents
Current Topics in Medicinal Chemistry 3-Bromopyruvate: A New Targeted Antiglycolytic Agent and a Promise for Cancer Therapy
Current Pharmaceutical Biotechnology Immune Dysfunction in Chronic Lymphocytic Leukemia: The Role for Immunotherapy
Current Pharmaceutical Design Perspectives Offered by Single-Domain Antibodies in Clinical Diagnostic of Pediatric Tumors
Current Medicinal Chemistry Gamma Secretase Inhibitor: Therapeutic Target via NOTCH Signaling in T Cell Acute Lymphoblastic Leukemia
Current Drug Targets P-Glycoprotein Mediated Multidrug Resistance Reversal by Phytochemicals: A Review of SAR & Future Perspective for Drug Design
Current Topics in Medicinal Chemistry A 1536-Well Fluorescence Polarization Assay to Screen for Modulators of the MUSASHI Family of RNA-Binding Proteins
Combinatorial Chemistry & High Throughput Screening Sirtuins Family- Recent Development as a Drug Target for Aging, Metabolism, and Age Related Diseases
Current Drug Targets Increase in the Non-HIV-Related Deaths Among Aids Cases in the HAART Era
Current HIV Research Review on Documented Medicinal Plants used for the Treatment of Cancer
Current Traditional Medicine Gene Therapy of Cancer Based on Interleukin 12
Current Gene Therapy Computed Tomography Contribution to Virtual Preoperative Liver Resection Planning
Recent Patents on Medical Imaging Nuclear Receptor SHP as a Potential Therapeutic Target for Liver Cancer
Current Cancer Therapy Reviews The Role of 3D Pharmacophore Mapping Based Virtual Screening for Identification of Novel Anticancer Agents: An Overview
Current Topics in Medicinal Chemistry Structure, Function, and Pathogenesis of SHP2 in Developmental Disorders and Tumorigenesis
Current Cancer Drug Targets